RU2002134754A - ANALOGUES OF FATTY ACIDS FOR TREATMENT OF CANCER - Google Patents
ANALOGUES OF FATTY ACIDS FOR TREATMENT OF CANCERInfo
- Publication number
- RU2002134754A RU2002134754A RU2002134754/15A RU2002134754A RU2002134754A RU 2002134754 A RU2002134754 A RU 2002134754A RU 2002134754/15 A RU2002134754/15 A RU 2002134754/15A RU 2002134754 A RU2002134754 A RU 2002134754A RU 2002134754 A RU2002134754 A RU 2002134754A
- Authority
- RU
- Russia
- Prior art keywords
- alkyl
- use according
- inhibiting
- group
- fatty acid
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title claims 5
- 239000000194 fatty acid Substances 0.000 title claims 5
- 150000004665 fatty acids Chemical class 0.000 title claims 5
- 201000011510 cancer Diseases 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 230000002401 inhibitory effect Effects 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 3
- VLUHZRATVZGZDC-UHFFFAOYSA-N 1-$l^{1}-selanylhexadecan-1-one Chemical compound CCCCCCCCCCCCCCCC([Se])=O VLUHZRATVZGZDC-UHFFFAOYSA-N 0.000 claims 2
- IPBCWPPBAWQYOO-UHFFFAOYSA-N Tetradecylthioacetic acid Chemical compound CCCCCCCCCCCCCCSCC(O)=O IPBCWPPBAWQYOO-UHFFFAOYSA-N 0.000 claims 2
- 125000004423 acyloxy group Chemical group 0.000 claims 2
- 150000001337 aliphatic alkines Chemical class 0.000 claims 2
- 150000001336 alkenes Chemical class 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- -1 chloro, hydroxy Chemical group 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 239000000651 prodrug Substances 0.000 claims 2
- 229940002612 prodrugs Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 210000004369 Blood Anatomy 0.000 claims 1
- 210000002808 Connective Tissue Anatomy 0.000 claims 1
- 206010061289 Metastatic neoplasm Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000029578 entry into host Effects 0.000 claims 1
- 238000005755 formation reaction Methods 0.000 claims 1
- 230000001394 metastastic Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000004083 survival Effects 0.000 claims 1
Claims (12)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20003591 | 2000-07-13 | ||
NO20003591A NO20003591L (en) | 2000-07-13 | 2000-07-13 | Fatty acid analogues for the treatment of cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2002134754A true RU2002134754A (en) | 2004-07-20 |
RU2283105C2 RU2283105C2 (en) | 2006-09-10 |
Family
ID=19911376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2002134754/15A RU2283105C2 (en) | 2000-07-13 | 2001-07-13 | Saturated acid analogs for cancer treatment |
Country Status (18)
Country | Link |
---|---|
US (1) | US7378443B2 (en) |
EP (1) | EP1313463B1 (en) |
JP (1) | JP2004502732A (en) |
KR (2) | KR20080071598A (en) |
CN (1) | CN100569228C (en) |
AT (1) | ATE320802T1 (en) |
AU (2) | AU2001272860B2 (en) |
BR (1) | BR0112399A (en) |
CA (1) | CA2414480A1 (en) |
DE (1) | DE60118198T2 (en) |
ES (1) | ES2261441T3 (en) |
HK (1) | HK1057473A1 (en) |
MX (1) | MXPA02012944A (en) |
NO (2) | NO20003591L (en) |
NZ (1) | NZ523316A (en) |
RU (1) | RU2283105C2 (en) |
WO (1) | WO2002003983A1 (en) |
ZA (1) | ZA200210028B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO328803B1 (en) | 2000-03-03 | 2010-05-18 | Thia Medica | New fatty acid analogues |
EP1515978A1 (en) | 2002-06-20 | 2005-03-23 | IC Vec Limited | Sulfur-containing phospholipid derivatives |
KR20070054637A (en) | 2004-07-19 | 2007-05-29 | 티아 메디카 에이에스 | Composition comprising plant and/or fish oils and non-oxidizable fatty acid entities |
NO20053519L (en) * | 2005-07-18 | 2007-01-19 | Thia Medica As | Use of compounds comprising fatty acids |
US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
US8650937B2 (en) | 2008-09-19 | 2014-02-18 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
CA2769030C (en) | 2009-07-30 | 2016-05-10 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
US10154979B2 (en) | 2013-03-11 | 2018-12-18 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
AU2014229506B2 (en) | 2013-03-11 | 2017-04-13 | Nobesita As | Natural lipids containing non-oxidizable fatty acids |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
DE102014116958B9 (en) * | 2014-11-19 | 2017-10-05 | Trumpf Laser- Und Systemtechnik Gmbh | Optical system for beam shaping of a laser beam, laser processing system, method for material processing and use of a common elongated focus zone for laser material processing |
US20180169159A1 (en) * | 2015-06-11 | 2018-06-21 | University Of Miami | Cancer treatment and diagnosis |
CN105498622B (en) * | 2015-12-10 | 2017-10-17 | 江南大学 | A kind of surfactant containing selenium and its preparation method and application |
CN107235880B (en) * | 2017-06-30 | 2018-10-30 | 江南大学 | One kind cationic surfactant containing selenium and its application |
GB201910644D0 (en) * | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
US11897888B1 (en) | 2020-04-30 | 2024-02-13 | Stinginn Llc | Small molecular inhibitors of sting signaling compositions and methods of use |
CN115260964A (en) * | 2022-08-29 | 2022-11-01 | 烟台市福山义昌精细化工厂 | Special sealant for petroleum oil pipe screw thread and preparation method thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0686377B2 (en) * | 1985-09-30 | 1994-11-02 | 日清製粉株式会社 | Cancer metastasis inhibitor |
JPH0797320A (en) * | 1993-08-04 | 1995-04-11 | Takuma Sasaki | Carcinostatic agent |
US6358915B1 (en) * | 1995-03-07 | 2002-03-19 | George Washington University | Methods for inhibiting metastasis |
DK0768084T3 (en) * | 1995-04-10 | 2002-10-14 | Taiho Pharmaceutical Co Ltd | cancer metastasis inhibitor |
NO952796D0 (en) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fatty acid analogues with non-oxidizable B-site, preparation and use in crepes |
WO1999058120A1 (en) * | 1998-05-08 | 1999-11-18 | Rolf Berge | USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS |
JP4993878B2 (en) * | 2005-06-28 | 2012-08-08 | ダイキョーニシカワ株式会社 | Multi-cylinder engine intake system |
-
2000
- 2000-07-13 NO NO20003591A patent/NO20003591L/en not_active Application Discontinuation
-
2001
- 2001-07-13 EP EP01952065A patent/EP1313463B1/en not_active Expired - Lifetime
- 2001-07-13 US US10/312,901 patent/US7378443B2/en not_active Expired - Fee Related
- 2001-07-13 KR KR1020087014318A patent/KR20080071598A/en not_active Application Discontinuation
- 2001-07-13 BR BR0112399-8A patent/BR0112399A/en not_active Application Discontinuation
- 2001-07-13 KR KR1020037000477A patent/KR100861428B1/en not_active IP Right Cessation
- 2001-07-13 AT AT01952065T patent/ATE320802T1/en not_active IP Right Cessation
- 2001-07-13 CN CNB018127177A patent/CN100569228C/en not_active Expired - Fee Related
- 2001-07-13 JP JP2002508437A patent/JP2004502732A/en active Pending
- 2001-07-13 CA CA002414480A patent/CA2414480A1/en not_active Abandoned
- 2001-07-13 AU AU2001272860A patent/AU2001272860B2/en not_active Ceased
- 2001-07-13 MX MXPA02012944A patent/MXPA02012944A/en active IP Right Grant
- 2001-07-13 NZ NZ523316A patent/NZ523316A/en not_active IP Right Cessation
- 2001-07-13 AU AU7286001A patent/AU7286001A/en active Pending
- 2001-07-13 RU RU2002134754/15A patent/RU2283105C2/en not_active IP Right Cessation
- 2001-07-13 DE DE60118198T patent/DE60118198T2/en not_active Expired - Fee Related
- 2001-07-13 ES ES01952065T patent/ES2261441T3/en not_active Expired - Lifetime
- 2001-07-13 WO PCT/NO2001/000301 patent/WO2002003983A1/en active IP Right Grant
-
2002
- 2002-12-11 NO NO20025930A patent/NO324634B1/en not_active IP Right Cessation
- 2002-12-11 ZA ZA200210028A patent/ZA200210028B/en unknown
-
2004
- 2004-01-15 HK HK04100292.1A patent/HK1057473A1/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2002134754A (en) | ANALOGUES OF FATTY ACIDS FOR TREATMENT OF CANCER | |
RU2223095C2 (en) | New analogs of fatty acids for treating primary and secondary restenosis | |
AU2007275658B2 (en) | Compositions and methods for the treatment of mucositis | |
GB9900334D0 (en) | Tricylic vascular damaging agents | |
JP2004502732A5 (en) | ||
RU2003109622A (en) | LIABILITY COMPOSITION | |
JP2004514663A5 (en) | ||
RU2000113729A (en) | HETEROCYCLIC COMPOUNDS FOR INHIBITING GASTRIC ACID SECRET, METHODS FOR PRODUCING THEM AND THEIR PHARMACEUTICAL COMPOSITIONS | |
RU97115713A (en) | COMPOUNDS CONTAINING PETROPYRANES AND METHOD OF APPLICATION | |
PT813423E (en) | COMPOSITION FOR INHIBITING OSTEOLYSIS AND METASTESE | |
RU2007138582A (en) | ORAL DOSAGE FORMS OF HEMCITABINE DERIVATIVES | |
RU2002123641A (en) | S-4 carbonate-containing taxanes | |
ATE320802T1 (en) | FATTY ACID ANALOGUES FOR TREATING CANCER | |
RU2004133387A (en) | PHARMACEUTICAL PRODUCT WITH IMMEDIATE RELEASE | |
RU2002101622A (en) | Naphthoquinone derivatives and their use for the treatment and control of tuberculosis | |
RU2008138749A (en) | CAMPTOTECINE DERIVATIVES AND THEIR APPLICATION | |
JP2002538109A5 (en) | ||
RU2004133388A (en) | NEW SALTS | |
RU2008138165A (en) | STEROID COMPOUNDS AS STEROID SULFATASE INHIBITORS | |
US6472381B1 (en) | Method of treating psoriasis | |
KR101760963B1 (en) | Pharmaceutical combination for treating tumor | |
JP5462504B2 (en) | Whitening composition | |
RU2004116067A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING MACROLIDES | |
RU2006132741A (en) | C10 CYCLOPENTIL ETHERIC TAXANS | |
KR900000383A (en) | New compounds |